Intralipid® 20%

(soya-bean oil)

For GB healthcare professionals only. This content contains promotional and brand information.
 
Scroll down for prescribing information for macronutrient parenteral nutrition products and further product information. Adverse event reporting details are available at the bottom of this webpage.
 
A lipid emulsion for intravenous infusion.
 
PN should be monitored, and doses adjusted according to individual patient response. Please refer to the Summary of Product Characteristics before prescribing.

Please note product image is for illustrative purposes only and labelling on actual products may appear differently.

Filename
Macronutrient Prescribing Information.pdf
Size
209 KB
Format
pdf
Macronutrient Prescribing Information.pdf

Details

 FatEnergyPhosphate* 

Intralipid® 20%

200g/l2000kcal/l15mmol/l


* Organic phosphate - this is considered to be bioavailable

 
  • Intralipid 20% may be given as a separate infusion or as an admixture - see SmPC for further information on administration
  • Contains purified soya-bean oil (long-chain triglycerides) 
  • Available in a range of pack sizes for flexibility and convenience

  • For use as part of a balanced intravenous feeding regimen in patients who are unable to receive sufficient amounts of nutrients enterally. Intralipid is especially valuable in providing a high energy intake to compensate for increased energy expenditure following trauma, infections, or severe burns 
  • See summary of product characteristics for use in different patient populations, including adults, children, infants and neonates

Item description Item codeUnit size  Case qty
Intralipid® 20% 831800220 100ml10
 831818220250ml10
 831826220500ml12

 


Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited.  Email: Pharmacovigilance.GB@fresenius-kabi.com

 

GB-Int-2400001 January 2025

By entering the Healthcare Professional Area you are confirming you are a GB Healthcare Professional. This area contains promotional information. If you are not a Healthcare Professional you will be directed to the Fresenius Kabi GB Corporate website.

GB-NP-2400163 October 2024